Wharton Business Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Wharton Business Group's AMGN Position: Q2 2026 in Review
Wharton Business Group increased its Amgen (AMGN) stake by 0.09% in Q2 2026, buying an estimated $342 and bringing the position to 1,173 shares worth $425K. The position accounts for 0.01% of the portfolio, ranked #106.
Wharton Business Group first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Wharton Business Group held 1,173 shares of Amgen worth $425K as of Q2 2026.
- Wharton Business Group bought 1 Amgen share in Q2 2026, an estimated $342.
- Amgen made up 0.01% of Wharton Business Group's portfolio in Q2 2026, its #106 holding.
- Wharton Business Group first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Wharton Business Group's 13F filing for Q2 2026, filed 10 Aug 2026.